InsidersTradesSigma
차바이오텍 Stock: price and management transactions · South Korea · DART (FSS)
Follow the 차바이오텍 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 차바이오텍 has recorded 94 reports. Market capitalisation: €872bn. The latest transaction was reported on 22 May 2026 (Other). Among the most active insiders: 차광렬. Every trade is openly available.
94
Insider Decl.
0
Thresholds
·
1 ops.
Buy Volume
€846,999
8 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 24,595 of 26,213 companies
17.5
score / 100
Value12
Quality24
FCF yld-24%
Earn yld-12%
EV/EBITDA·
ROE-14%
Gross mgn29%
Net mgn-8.7%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 22 May 2026
Declarations94 total
25 of 94 declarations